PDSB
Price
$5.26
Change
+$0.12 (+2.33%)
Updated
Nov 30, 6:59 PM EST
119 days until earnings call
VERA
Price
$13.55
Change
+$0.20 (+1.50%)
Updated
Nov 30, 6:59 PM EST
112 days until earnings call
Ad is loading...

Compare predictions PDSB vs VERA

Header iconPDSB vs VERA Comparison
Open Charts PDSB vs VERABanner chart's image
PDS Biotechnology
Price$5.26
Change+$0.12 (+2.33%)
Volume$468K
CapitalizationN/A
Vera Therapeutics
Price$13.55
Change+$0.20 (+1.50%)
Volume$243.7K
CapitalizationN/A
View a ticker or compare two or three
PDSB vs VERA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
PDSB vs. VERA commentary
Dec 01, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PDSB is a Hold and VERA is a StrongBuy.

COMPARISON
Comparison
Dec 01, 2023
Stock price -- (PDSB: $5.26 vs. VERA: $13.55)
Brand notoriety: PDSB and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PDSB: 89% vs. VERA: 51%
Market capitalization -- PDSB: $183.54M vs. VERA: $574.96M
PDSB [@Biotechnology] is valued at $183.54M. VERA’s [@Biotechnology] market capitalization is $574.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PDSB’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • PDSB’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than PDSB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PDSB’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 6 bullish TA indicator(s).

  • PDSB’s TA Score: 5 bullish, 5 bearish.
  • VERA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than PDSB.

Price Growth

PDSB (@Biotechnology) experienced а -14.61% price change this week, while VERA (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.35%. For the same industry, the average monthly price growth was +26.89%, and the average quarterly price growth was +20.28%.

Reported Earning Dates

PDSB is expected to report earnings on Mar 28, 2024.

VERA is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (+2.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PDSB with price predictions.
OPEN
A.I.dvisor published
a Summary for VERA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VERA($575M) has a higher market cap than PDSB($184M). VERA YTD gains are higher at: -29.974 vs. PDSB (-60.152). PDSB has higher annual earnings (EBITDA): -48.62M vs. VERA (-99.44M). VERA has more cash in the bank: 160M vs. PDSB (54.3M). PDSB has less debt than VERA: PDSB (23.6M) vs VERA (29.5M). PDSB (0) and VERA (0) have equivalent revenues.
PDSBVERAPDSB / VERA
Capitalization184M575M32%
EBITDA-48.62M-99.44M49%
Gain YTD-60.152-29.974201%
P/E RatioN/AN/A-
Revenue00-
Total Cash54.3M160M34%
Total Debt23.6M29.5M80%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PDSBVERA
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Bullish Trend 1 day ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARIFX10.19N/A
N/A
Aristotle International Eq I
FFAMX18.80N/A
N/A
Fidelity Advisor Asset Manager® 50% A
FSCIX29.42N/A
N/A
Fidelity Advisor® Small Cap I
TVFRX15.18N/A
N/A
Guggenheim Directional Allocation P
LVAMX11.57N/A
N/A
LSV US Managed Volatility Investor

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+2.33%
AXON - PDSB
43%
Loosely correlated
+1.78%
MDGL - PDSB
38%
Loosely correlated
+3.01%
VCYT - PDSB
37%
Loosely correlated
-0.51%
VERA - PDSB
35%
Loosely correlated
+1.50%
ARRY - PDSB
35%
Loosely correlated
+3.76%
More